Vanguard Group’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.8M Sell
3,802,646
-31,722
-0.8% -$299K ﹤0.01% 2278
2025
Q1
$20.8M Buy
3,834,368
+31,141
+0.8% +$169K ﹤0.01% 2489
2024
Q4
$28.3M Buy
3,803,227
+755,045
+25% +$5.63M ﹤0.01% 2416
2024
Q3
$24.4M Buy
3,048,182
+273,728
+10% +$2.19M ﹤0.01% 2500
2024
Q2
$24.1M Buy
2,774,454
+378,226
+16% +$3.29M ﹤0.01% 2472
2024
Q1
$49.5M Buy
2,396,228
+362,168
+18% +$7.49M ﹤0.01% 2170
2023
Q4
$47M Buy
2,034,060
+593,336
+41% +$13.7M ﹤0.01% 2212
2023
Q3
$11.5M Buy
1,440,724
+37,486
+3% +$300K ﹤0.01% 2809
2023
Q2
$12.2M Buy
1,403,238
+4,205
+0.3% +$36.6K ﹤0.01% 2826
2023
Q1
$4.11M Buy
1,399,033
+3,447
+0.2% +$10.1K ﹤0.01% 3395
2022
Q4
$4.88M Sell
1,395,586
-2,902
-0.2% -$10.2K ﹤0.01% 3321
2022
Q3
$11.1M Buy
1,398,488
+43,170
+3% +$341K ﹤0.01% 2914
2022
Q2
$10.7M Buy
1,355,318
+122,517
+10% +$964K ﹤0.01% 2959
2022
Q1
$15M Buy
1,232,801
+43,831
+4% +$533K ﹤0.01% 2932
2021
Q4
$14.6M Buy
1,188,970
+96,664
+9% +$1.18M ﹤0.01% 3016
2021
Q3
$11.4M Buy
1,092,306
+5,977
+0.6% +$62.3K ﹤0.01% 3162
2021
Q2
$9.77M Buy
1,086,329
+181,890
+20% +$1.64M ﹤0.01% 3211
2021
Q1
$9.19M Buy
904,439
+582,736
+181% +$5.92M ﹤0.01% 3193
2020
Q4
$2.12M Sell
321,703
-27
-0% -$178 ﹤0.01% 3646
2020
Q3
$1.67M Sell
321,730
-8,046
-2% -$41.7K ﹤0.01% 3536
2020
Q2
$2.5M Sell
329,776
-20,467
-6% -$155K ﹤0.01% 3368
2020
Q1
$3.57M Buy
350,243
+50,369
+17% +$514K ﹤0.01% 3115
2019
Q4
$4.65M Sell
299,874
-914
-0.3% -$14.2K ﹤0.01% 3195
2019
Q3
$5.44M Buy
300,788
+32,459
+12% +$587K ﹤0.01% 3109
2019
Q2
$4.4M Sell
268,329
-10,477
-4% -$172K ﹤0.01% 3211
2019
Q1
$4.99M Buy
278,806
+26,024
+10% +$466K ﹤0.01% 3141
2018
Q4
$4.78M Buy
252,782
+72,911
+41% +$1.38M ﹤0.01% 3107
2018
Q3
$6.42M Buy
179,871
+4,736
+3% +$169K ﹤0.01% 3139
2018
Q2
$3.64M Buy
175,135
+7,542
+5% +$157K ﹤0.01% 3316
2018
Q1
$2.05M Buy
167,593
+10,797
+7% +$132K ﹤0.01% 3457
2017
Q4
$1.69M Buy
156,796
+44,589
+40% +$481K ﹤0.01% 3475
2017
Q3
$1.35M Buy
112,207
+2,315
+2% +$27.8K ﹤0.01% 3512
2017
Q2
$1.88M Sell
109,892
-4,688
-4% -$80.2K ﹤0.01% 3400
2017
Q1
$1.97M Buy
114,580
+3,889
+4% +$66.9K ﹤0.01% 3386
2016
Q4
$1.89M Buy
110,691
+12,579
+13% +$215K ﹤0.01% 3378
2016
Q3
$2.95M Buy
98,112
+2,738
+3% +$82.4K ﹤0.01% 3236
2016
Q2
$2.7M Buy
95,374
+1,287
+1% +$36.4K ﹤0.01% 3255
2016
Q1
$2.52M Buy
94,087
+18,509
+24% +$496K ﹤0.01% 3293
2015
Q4
$3.64M Buy
75,578
+2,110
+3% +$102K ﹤0.01% 3130
2015
Q3
$2.68M Buy
73,468
+1,523
+2% +$55.6K ﹤0.01% 3242
2015
Q2
$2.71M Buy
71,945
+1,210
+2% +$45.6K ﹤0.01% 3294
2015
Q1
$2.79M Buy
70,735
+4,509
+7% +$178K ﹤0.01% 3272
2014
Q4
$2.72M Buy
66,226
+2,018
+3% +$82.9K ﹤0.01% 3166
2014
Q3
$2.84M Buy
64,208
+2,833
+5% +$125K ﹤0.01% 3120
2014
Q2
$2.66M Hold
61,375
﹤0.01% 3132
2014
Q1
$2.52M Buy
61,375
+18,185
+42% +$745K ﹤0.01% 3119
2013
Q4
$1.72M Buy
43,190
+6,054
+16% +$240K ﹤0.01% 3248
2013
Q3
$1.53M Buy
37,136
+3,091
+9% +$127K ﹤0.01% 3241
2013
Q2
$1.32M Buy
+34,045
New +$1.32M ﹤0.01% 3219